Efficacy of early treatment with favipiravir on disease progression among high-risk patients with coronavirus disease 2019 (COVID-19): a randomized, open-label …
Background The role of favipiravir in preventing disease progression in coronavirus disease
2019 (COVID-19) remains uncertain. We aimed to determine its effect in preventing disease …
2019 (COVID-19) remains uncertain. We aimed to determine its effect in preventing disease …
Efficacy of Early Treatment With Favipiravir on Disease Progression Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19): A Randomized, Open …
CH Chuah, TS Chow, CP Hor… - Clinical Infectious …, 2022 - search.ebscohost.com
Background The role of favipiravir in preventing disease progression in coronavirus disease
2019 (COVID-19) remains uncertain. We aimed to determine its effect in preventing disease …
2019 (COVID-19) remains uncertain. We aimed to determine its effect in preventing disease …
Efficacy of Early Treatment With Favipiravir on Disease Progression Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19): A Randomized, Open …
CH Chuah, TS Chow, CP Hor, JT Cheng… - Clinical Infectious …, 2022 - academic.oup.com
Background The role of favipiravir in preventing disease progression in coronavirus disease
2019 (COVID-19) remains uncertain. We aimed to determine its effect in preventing disease …
2019 (COVID-19) remains uncertain. We aimed to determine its effect in preventing disease …
Efficacy of Early Treatment With Favipiravir on Disease Progression Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19): A Randomized, Open …
CH Chuah, TS Chow, CP Hor, JT Cheng… - … Diseases: an Official …, 2022 - europepmc.org
Background The role of favipiravir in preventing disease progression in coronavirus disease
2019 (COVID-19) remains uncertain. We aimed to determine its effect in preventing disease …
2019 (COVID-19) remains uncertain. We aimed to determine its effect in preventing disease …
Efficacy of early treatment with favipiravir on disease progression among high-risk patients with coronavirus disease 2019 (COVID-19): a randomized, open-label …
CH Chuah, TS Chow, CP Hor, JT Cheng, HB Ker… - 2021 - cabidigitallibrary.org
Background: The role of favipiravir in preventing disease progression in coronavirus disease
2019 (COVID-19) remains uncertain. We aimed to determine its effect in preventing disease …
2019 (COVID-19) remains uncertain. We aimed to determine its effect in preventing disease …
[PDF][PDF] Efficacy of Early Treatment With Favipiravir on Disease Progression Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19): A Randomized …
CH Chuah, TS Chow, CP Hor, JT Cheng, HB Ker… - infection, 2021 - researchgate.net
Background. The role of favipiravir in preventing disease progression in coronavirus disease
2019 (COVID-19) remains uncertain. We aimed to determine its effect in preventing disease …
2019 (COVID-19) remains uncertain. We aimed to determine its effect in preventing disease …
Efficacy of Early Treatment With Favipiravir on Disease Progression Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19): A Randomized, Open …
CH Chuah, TS Chow, CP Hor, JT Cheng, HB Ker… - 2022 - pubmed.ncbi.nlm.nih.gov
Background The role of favipiravir in preventing disease progression in coronavirus disease
2019 (COVID-19) remains uncertain. We aimed to determine its effect in preventing disease …
2019 (COVID-19) remains uncertain. We aimed to determine its effect in preventing disease …